INTRODUCTION
There are two evolutionarily conserved defense strategies against infection that limit host disease severity. One relies on the capacity of the host's innate and adaptive immune system to reduce pathogen burden, i.e., resistance to infection. The salutary effects of this defense strategy are illustrated by the protective effect of vaccination against a wide range of infectious diseases. There is, however, another host defense strategy that limits disease severity irrespectively of pathogen burden, i.e., disease tolerance (Ayres and Schneider, 2012; Medzhitov et al., 2012; Schneider and Ayres, 2008) . Revealed originally in plants and thereafter in flies, disease tolerance also operates in mammals, as demonstrated for Plasmodium (Rå berg et al., Seixas et al., 2009 ) and polymicrobial (Larsen et al., 2010) infection in mice.
Once infected, mammals restrict Fe availability to pathogens, reducing Fe acquisition via gut epithelial cells while inhibiting cellular Fe export and sequestering intracellular Fe within different tissues (Ganz, 2009; Weiss, 2002) . A major ''trade-off'' of this host defense strategy is tissue Fe overload, which can act in a pro-oxidant and cytotoxic manner to promote tissue damage and exacerbate disease severity. Presumably, this pathologic outcome is countered by a series of mechanisms providing host metabolic adaptation to tissue Fe overload. We hypothesized that these mechanisms involve the expression of ferritin H chain (Fth), a stress-responsive gene (Torti et al., 1988 ) that regulates Fe metabolism (Harrison and Arosio, 1996; Hentze and Kü hn, 1996; Vanoaica et al., 2010) .
FtH is an evolutionarily conserved Fe sequestering protein that acts in a cytoprotective manner (Balla et al., 1992; Berberat et al., 2003; Cozzi et al., 2003; Pham et al., 2004) . This cytoprotective effect relies on the ferroxidase activity of FtH, which converts Fe(II) into Fe(III), hence limiting the participation of Fe(II) in the production of free radicals via the Fenton chemistry (Pham et al., 2004) . The antioxidant effect of FtH inhibits c-Jun N-terminal kinase (JNK) activation in vitro through a mechanism targeting redox-sensitive phosphates and conferring cytoprotection (Chang et al., 2006; Kamata et al., 2005; Pham et al., 2004) . We now demonstrate that inhibition of JNK activation by FtH confers tolerance to malaria, the disease caused by Plasmodium infection. C57BL/6 mice. Moreover, there was no induction of FtH or FtL protein ( Figure S1D ) or mRNA ( Figure S1E , data not shown) expression in heart, lung, kidney, or spleen of Pcc-infected C57BL/6 mice. C57BL/6 Fth lox/lox mice, carrying a Fth allele flanked by LoxP sites and expressing physiologic levels of FtH (Figures S1F and S1G) (Darshan et al., 2009) , cleared Pcc infection without overt lethality ( Figure 1B ). In contrast, C57BL/6 Fth D/D mice, in which the Fth lox/lox allele was deleted by the expression of Cre recombinase under the control of the Mx1 promoter (Darshan et al., 2009; Kü hn et al., 1995) , did not express FtH in the liver (Figure S1F) and peripheral blood ( Figure S1G ), succumbing to Pcc infection ( Figure 1B Figure S1 .
widespread hepatocyte programmed cell death (PCD) ( Figure 1D ) and accumulation of aspartate aminotransferase (AST) in plasma ( Figure 1E ). This was associated with liver Fe overload (Figure 1F) . Fe chelation by Deferasirox (Exjade) protected Fth D/D from infection ( Figure 1G ) without interfering with parasitemia ( Figure 1H ). This shows that FtH prevents the deleterious effects of tissue iron overload and confers tolerance to malaria in mice. Expression of HO-1, a stress-responsive gene that confers tolerance to malaria in mice (Ferreira et al., 2008 (Ferreira et al., , 2011 Pamplona et al., 2007; Seixas et al., 2009) Pcc infection is lethal in DBA/2 mice (Seixas et al., 2009) , an outcome associated with delayed FtH mRNA ( Figure S2A ) and protein ( Figure 2A ) expression as well as with liver Fe overload ( Figure 2B ), as compared to C57BL/6 mice. There was no induction of FtL mRNA ( Figure S2B ) or protein (Figure 2A) expression in response to Pcc infection. Transduction of DBA/2 mice with a recombinant adenovirus (Rec.Ad.) encoding FtH ( Figure 2C ) was protective against Pcc infection ( Figure 2D ), irrespectively of pathogen load ( Figure 2D and Figures S2C and S2D ). Transduction with a Rec.Ad. encoding a mutated form of FtH ( m FtH) lacking ferroxidase activity (Broxmeyer et al., 1991; Lawson et al., 1989) Rec.Ad. was also protective against liver damage in P. berghei ANKA-infected DBA/2 ( Figure S2E ) or C57BL/6 (Figure S2F) mice (Adachi et al., 2001 ). This protective effect was not associated with modulation of parasitemia (Figures S2G and S2H) , showing that the ferroxidase activity of FtH confers disease tolerance to malaria.
The Cytoprotective Effect of FtH Confers Tolerance to Malaria
Plasmodium infection is associated with accumulation of heme in plasma, as demonstrated in mice (Ferreira et al., 2011; Pamplona et al., 2007) as well as in humans (Andrade et al., 2010a) . When released from hemoproteins, heme sensitizes hepatocytes to undergo PCD, causing liver damage and compromising host survival irrespectively of pathogen burden Larsen et al., 2010; Seixas et al., 2009 Figure 3A ). This was associated with suppression of caspase-3 cleavage/activation in vitro (Figure 3B ) as well as in vivo ( Figure 3C ), as assessed in the liver of DBA/2 mice transduced with FtH versus m FtH or LacZ Rec.Ad..
Pharmacologic caspase-3 (z-DEVD-fmk) or broad-caspase (z-VAD-fmk) inhibition protected primary hepatocytes from PCD in vitro ( Figure 3D ), showing that heme and TNF induce PCD via a mechanism involving caspase activation. We asked whether the cytotoxic effect of heme acts via a mechanism involving nuclear factor kappa B (NF-kB), a transcription factor that regulates PCD (Beg and Baltimore, 1996) . Heme did not modulate NF-kB activation in response to TNF, as assessed in vitro using a NF-kB-luciferase reporter assay in primary mouse hepatocytes ( Figure 3E ). Transduction with FtH versus m FtH or LacZ Rec.Ad. did not modulate NF-kB activation in response to heme and/or TNF ( Figure 3E ). The same was true for primary Fth D/D versus Fth lox/lox hepatocytes ( Figure S3A ). This shows that neither heme nor FtH modulate NF-kB activation in response to TNF in vitro.
Pcc infection was associated with NF-kB activation, as assessed in the liver of DBA/2 mice using an NF-kB-luciferase reporter assay ( Figure 3F ). NF-kB activity was induced to a similar extent in the liver of Pcc-infected DBA/2 versus C57BL/6 mice ( Figure S3B ). Transduction of DBA/2 mice with FtH Rec.Ad. failed to modulate NF-kB activation in response to Pcc infection, as compared to controls transduced with m FtH or LacZ Rec.Ad. (Figure 3F ). This suggests that FtH does not modulate NF-kB activation during Pcc infection.
While transduction with a Rec.Ad. encoding the NF-kB inhibitor alpha (IkBa) ( Figure S3C ) sensitized hepatocytes to undergo PCD in response to TNF ( Figure S3D ) (Soares et al., 1998; Wang et al., 1996) , as assessed at 24 hr ( Figure S3D ), it did not modulate the cytotoxic effect of heme and TNF, as assessed at 6 hr after heme and TNF exposure ( Figure S3E ). This suggests that heme and TNF induce PCD irrespectively of canonical NF-kB activation.
The Cytoprotective Effect of FtH Relies on Its Antioxidant Activity
The protective effect of FtH against Pcc infection was not associated with modulation of Tnf mRNA expression, as assessed
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-- ( Figure S4B ). Concentration of TNF ( Figure S4C ), total heme ( Figure S4D ), or heme not bound to hemoglobin ( Figure S4E ) was also similar in the plasma of Pcc-infected DBA/2 mice transduced with FtH versus m FtH or LacZ Rec.Ad. This suggests that it is the cytoprotective effect FtH that confers tolerance to malaria.
Transduction of hepatocytes in vitro with an FtH Rec.Ad. reduced the accumulation of free radicals ( Figure 4A Figure 4E ). Moreover, NAC as well as N-acetylcysteine amide (NACA) protected DBA/2 mice from Pcc infection without interfering with parasitemia ( Figure 4F ). These observations link the protective effect of FtH with its antioxidant activity.
Ferritin Expression Is Associated with Reduced Liver Damage in Human Malaria
Similar to mice ( Figures 1B, 1D , 1E, S2E, and S2F), individuals developing symptomatic forms of malaria in response to Plasmodium vivax infection presented varying levels of hepatic dysfunction/damage, as quantified according to AST, C reactive protein (CRP), and total bilirubin concentration in plasma ( Figure 5 ; Table S1 ) (Andrade et al., 2010c ) (see Supplemental Information). We have previously shown that these individuals have higher concentrations of non-hemoglobin-bound (free) heme and TNF in the plasma, as compared to noninfected individuals ( (F) Survival and mean parasitemia ± SD of Pcc-infected DBA/2 mice receiving vehicle (PBS; n = 5), NAC (n = 5), or NACA (n = 5). NAC and NACA were administered at 15 mg/kg every 12 hr, i.p., from days 4 to 15 postinfection. See also Figure S4 .
( Figure 5B ) in the plasma of individuals developing symptomatic forms of malaria were associated with increased hepatic dysfunction/damage. Ferritin concentration in plasma was higher in individuals infected with Plasmodium vivax versus noninfected individuals (median and interquartile range: malaria patients 64.77, 23.58-135 ng/ml, n = 161; noninfected donors 26.5, 16.5-40 ng/ml, n = 30, respectively; p < 0.001). However, among individuals developing symptomatic forms of malaria, higher ferritin concentrations in plasma were associated with reduced severity of liver dysfunction/damage ( Figure 5C ). There was no correlation between severity of liver dysfunction/damage and pathogen load, as determined by number of parasites in blood ( Figure 5D ). Higher concentrations of IL-6 and CRP in plasma were associated with lower ferritin concentrations ( Figures 5E and 5F ). This suggests that ferritin confers tolerance to malaria in humans and that unfettered inflammation, Figure S5 and Table S1. i.e., high IL-6 and CRP, is associated with decreased ferritin expression.
Transferrin saturation (TSAT; i.e., ratio of serum iron and total iron-binding capacity) was increased in individuals infected with Plasmodium vivax, as compared to noninfected individuals (median and interquartile range: malaria patients 33, 23%-50%, n = 161; noninfected donors 20.0, 18.0%-35.75%, n = 30, respectively; p < 0.001). In contrast to ferritin, higher TSAT in individuals developing symptomatic forms of malaria was associated with increased severity of liver dysfunction/damage ( Figure S5A ), irrespectively of pathogen burden (Figure S5B) , which is consistent with previous studies (Das et al., 1997) . Higher concentrations of IL-6 ( Figure S5C ), CRP ( Figure S5D ), and heme ( Figure S5E ) in plasma were associated with increased TSAT. Moreover, there was an inverse correlation between TSAT and ferritin concentration in plasma ( Figure S5F ), suggesting that unfettered inflammation dissociates ferritin expression from the iron status of individuals developing symptomatic forms of malaria.
FtH Inhibits JNK Activation during Plasmodium Infection JNK was activated in a sustained manner in hepatocytes exposed in vitro to heme plus TNF ( Figure 6A) . A similar effect was observed in vivo, in the liver of Pcc-infected DBA/2 mice ( Figure S6A ). Inhibition of JNK1/2 expression using an shRNA Rec.Ad. protected primary mouse hepatocytes from undergoing PCD in vitro ( Figure 6B Figure 6E ). NAC inhibited JNK1/2 activation in hepatocytes in vitro ( Figure 6F ) as well as in vivo in the liver of Pcc-infected DBA/2 mice (Figure 6G ). This suggests that the antioxidant effect of FtH inhibits JNK1/2 activation in vitro as well as in vivo during Plasmodium infection.
JNK and FtH Crossregulate Each Other to Control Tolerance to Malaria
In keeping with previous findings suggesting that JNK contributes to the pathogenesis of severe malaria in mice (Lu et al., 2006) , we asked whether sustained JNK activation promotes liver damage associated with Plasmodium infection. JNK1/2 expression and activity were inhibited in the liver of DBA/2 mice by transduction, 3 days before Pcc infection, of shRNA Rec.Ad. targeting JNK1/2 (shJNK) versus a control scrambled (shScr) Rec.Ad. (Figures S6C and S6D ). JNK inhibition was protective against Pcc infection, revealed by reduced lethality ( Figure 7A ). This was associated with inhibition of liver damage, revealed by reduced AST concentration in plasma ( Figure 7B ) as well as caspase-3 activation ( Figure 7C ) and PCD ( Figure S6E ) in the liver. This was not associated with modulation of pathogen burden ( Figures 7A, S7A , and S7B) or modulation of TNF (Figure S7C ) and heme ( Figures S7D and S7E ) concentration in plasma. This suggests that FtH confers tolerance to malaria via a mechanism involving JNK inhibition. Pharmacologic inhibition of JNK activation using two distinct molecules, i.e., JNKi.SP ( Figure 7D ) or JNKi (data not shown), protected DBA/2 mice from Pcc infection without interfering with parasitemia ( Figure 7D ). This shows that JNK inhibition can act therapeutically to confer tolerance to malaria.
Transduction of hepatocytes in vitro with an shRNA Rec.Ad. targeting JNK1/2 was associated with induction of FtH and FtL protein ( Figure S7F ) as well as Fth mRNA (data not shown) expression in response to heme and TNF, as compared to control hepatocytes transduced with shScr Rec.Ad. A similar effect was observed for FtL protein ( Figure S7F ), but not for Ftl mRNA (data not shown) expression. This is consistent with the notion that JNK can inhibit ferritin expression in vitro (Antosiewicz et al., 2007) .
Inhibition of JNK expression in vivo was associated with increased FtH and FtL protein ( Figure 7E ) as well as Fth and Ftl mRNA (data not shown) expression, as assessed in the liver of Pcc-infected DBA/2 mice, transduced 3 days before infection with shJNK versus shScr Rec.Ad. (Figure 7E , data not shown). Induction of FtH expression in DBA/2 mice transduced with shJNK versus shScr Rec.Ad. was associated with a reduction of liver Fe overload ( Figure S7G ). This suggests that JNK controls liver Fe overload during Pcc infection via a mechanism targeting the expression of FtH.
Pharmacologic JNK inhibition suppressed the accumulation of free radicals in hepatocytes exposed to heme plus TNF in vitro ( Figure S7H ), suggesting that JNK activation acts in pro-oxidant manner via downregulation of FtH expression (Figure S7F) . Pharmacologic JNK inhibition failed to protect Fth Figure S7I ). This suggests that (1) the cytotoxic effect of JNK acts in vitro and in vivo via a mechanism involving the downregulation FtH expression and (2) the protective effect of JNK inhibition is dependent on the expression of FtH.
Given that NF-kB can regulate FtH expression (Kwak et al., 1995; Pham et al., 2004) , we asked whether JNK regulates FtH expression via a mechanism involving NF-kB. Transduction of primary mouse hepatocytes with shJNK versus shScr Rec.Ad. did not modulate NF-kB activation in response to heme and/or TNF, as assessed in vitro using an NF-kB luciferase assay (Figure S7J ). This suggests that JNK regulates FtH expression via a mechanism that does not involve NF-kB.
DISCUSSION
Resistance to infection, such as afforded by vaccination, confers protection against a broad range of infectious diseases. Given its overwhelming success, it has been difficult to understand why vaccination has so far failed to provide robust protection against specific infectious diseases such as malaria (Agnandji et al., 2011) . This may be explained by the recognition that protection against malaria relies on an additional host defense strategy that does not target directly the pathogen, i.e., disease tolerance (Medzhitov et al., 2012; Rå berg et al., 2007; Seixas et al., 2009 ). Life-threatening complications of malaria are driven by multiorgan dysfunction/damage associated with unfettered inflammation (Miller et al., 2002) . Heme accumulation in the plasma of individuals developing symptomatic forms of malaria (Andrade et al., 2010a) acts in a cytotoxic manner Seixas et al., 2009) , contributing in a critical manner to the pathogenesis of severe forms of malaria in mice (Ferreira et al., 2008 (Ferreira et al., , 2011 Pamplona et al., 2007; Seixas et al., 2009 ). In keeping with this notion, expression of stress-responsive genes that counter the deleterious effects of heme, e.g., the heme catabolizing enzyme HO-1, provide tissue damage control and confer tolerance to malaria in mice (Ferreira et al., 2011; Pamplona et al., 2007; Seixas et al., 2009; Soares et al., 2009 ). The pathophysiologic relevance of this host protective response is supported by the finding that sickle trait, selected through human evolution based on its ability to confer protection against malaria, acts via activation of this stress-responsive pathway to confer disease tolerance to malaria (Ferreira et al., 2011; Rosenthal, 2011) . Whether the protective effect of HO-1 impacts on the outcome of human malaria is not clear (Mendonç a et al., 2012; Sambo et al., 2010; Walther et al., 2012) .
As demonstrated hereby, the mechanism underlying tolerance to malaria involves another stress-responsive gene, namely FtH, a Fe-sequestering protein that regulates Fe metabolism (Darshan et al., 2009; Harrison and Arosio, 1996; Hentze et al., 1987) , limiting the cytotoxic effect of labile Fe (Balla et al., 1992; Berberat et al., 2003; Cozzi et al., 2003; Pham et al., 2004) . Expression of FtH is induced in response to Plasmodium infection in mice ( Figures 1A, 2A , and S1A-S1C) as well as in humans (Das et al., 1997) . Presumably, the mechanism regulating the induction of FtH expression during malaria acts at a posttranscriptional level, driven by Fe generated through heme catabolism by HO-1 ( Figure 1J ) (Berberat et al., 2003; Eisenstein et al., 1991) . Whether induction of FtH correlates with a threshold of parasitemia is not clear.
The salutary effect of FtH against Plasmodium infection acts irrespectively of pathogen load, conferring disease tolerance to malaria in mice (Figures 1 and 2 ) and presumably in humans (Figure 5 ). This suggests that individuals failing to upregulate the expression of FtH might be at higher risk of developing severe forms of malaria.
The cytoprotective effect of FtH relies on its ferroxidase activity (Figures 2 and 3) (Balla et al., 1992; Berberat et al., 2003; Cozzi et al., 2003; Pham et al., 2004) , which limits the participation of labile Fe in the Fenton chemistry, thus inhibiting the production of free radicals (Figure 4 ). This in turn inhibits sustained JNK activation, as demonstrated in vitro ( Figure 6C ) as well as in vivo ( Figures 6D and 6E) . The salutary effects of FtH are mimicked by pharmacologic antioxidants such as NAC or NACA ( Figures 4E and 4F ). These inhibit JNK activation in vitro ( Figure 6F ) as well as in vivo ( Figure 6G ), conferring tolerance to malaria in mice ( Figures 4E and 4F) .
Sustained JNK activation, catalyzed by labile Fe produced during Plasmodium infection, plays a central role in the pathogenesis of severe malaria in mice (Figure 7 ). This notion is in keeping with the previous observation that deletion of the Jnk2 allele confers protection against experimental cerebral malaria in mice (Lu et al., 2006) , without interfering with pathogen load ( Figures 7A, 7D , S7A, and S7B) (Lu et al., 2006) . This suggests that targeting JNK activation might be used therapeutically to confer tolerance to malaria, which we found to be the case in mice ( Figure 7D) .
The mechanism via which JNK activation compromises tolerance to malaria involves the inhibition of FtH expression ( Figures 7E, 7F , and S7F), leading to tissue Fe overload ( Figure S7G ), accumulation of free radicals ( Figure S7H ), cytotoxicity ( Figures 6B, 7C , and S6B), tissue damage (Figures 7B and S6E) , and ultimately host mortality ( Figures 7A and 7D) . We propose that induction of FtH expression during Plasmodium infection prevents pro-oxidant labile Fe from sustaining JNK activation, presumably via a mechanism involving the inhibition of redox-sensitive phosphatases regulating directly JNK activity (Chang et al., 2006; Kamata et al., 2005; Pham et al., 2004) . Induction of FtH expression requires the expression of HO-1 (Figure 1J ), thus suggesting that FtH contributes in a critical manner to the salutary effect of HO-1 against malaria (Figure S1H) (Seixas et al., 2009; Soares et al., 2009 (Darshan et al., 2009; Kü hn et al., 1995) .
Infections
Mice were infected intraperitoneally (i.p.) with 10 7 Plasmodium chabaudi chabaudi (Pcc) AS strain or 10 6 Plasmodium berghei ANKA-infected RBCs, referred to throughout the text as infection. Survival and parasitemia were monitored daily as described (Pamplona et al., 2007; Seixas et al., 2009 ).
Primary Mouse Hepatocytes and Cytotoxicity Assay
Primary mouse hepatocytes were isolated essentially as described (Gonç alves et al., 2007; Seixas et al., 2009) , and cytotoxicity was assessed as described Larsen et al., 2010; Seixas et al., 2009 ).
Cell Culture and Reagents Hepa 1-6 cells (C57BL/6 mouse liver hepatoma; ATCC, Barcelona, Spain) were cultured in DMEM (Invitrogen, Barcelona, Spain), 10% FCS, penicillin (20 U/ml), and streptomycin (20 U/ml) (Invitrogen) (37 C, 95% humidity, 5%
CO 2 ), as described (Larsen et al., 2010; Seixas et al., 2009 
Histopathology
Mice were perfused in toto with ice-cold PBS. Liver samples were harvested, fixed in 4% paraformaldehyde (PFA), embedded in paraffin, and stained with hematoxylin and eosin as described (Pamplona et al., 2007) . Detection of fragmented DNA in liver was carried out using the TUNEL method (In Situ Cell Death Detection Kit, Roche). FtH staining was performed as follows: Liver samples were collected in Tissue-Tek (Sakura), snap frozen in liquid nitrogen, and kept at À80 C until used. Liver samples were fixed in 1% PFA (15 min) and permeabilized with Triton X-100 (10 min), blocked with 5% goat serum and 1% BSA (60 min), and incubated with rabbit-anti-mouse FtH (1:100 dilution, overnight at 4 C) diluted in the same solution. Goat-anti-rabbit-Cy5 (1:300 dilution, 60 min) was used as a secondary antibody. DAPI reagent (15 min) was employed as nuclear stain. Cell autofluorescence (green; excitation l = 480 nm, emission l = 505) was used to detect hepatocyte morphology.
Human Samples
Plasma was collected between 2006 and 2007 from symptomatic individuals (N = 161) infected with Plasmodium vivax in Buritis, Rondô nia, Brazil, as described before (Andrade et al., 2010a (Andrade et al., , 2010b (Andrade et al., , 2010c (Andrade et al., , 2011 . Malaria diagnosis was performed using microscopic examination of thick smears and confirmed by qualitative nested PCR, as described (Andrade et al., 2009) . Parasitemia was expressed as parasites/ml. Plasma samples from 30 ageand sex-matched healthy and noninfected individuals from the same malaria endemic area were used to compare ferritin and transferrin saturation levels with the cohort of individuals infected with Plasmodium vivax.
Hepatic Damage Score
Aspartate transaminase (AST), total bilirubin, and c-reactive protein (CRP) were measured in plasma samples obtained from individuals with P. vivax malaria in order to build a scoring system allowing us to assess in a quantitative manner hepatic damage severity (adapted from Andrade et al., 2010c) . These parameters were measured at the clinical laboratory of Faculdade Sã o Lucas and at the Pharmacy School of the Federal University of Bahia, Brazil.
Statistical Analysis
Data analysis was performed using unpaired Student's t test for data presenting Gaussian distributions, an assumption tested using the Kolmogorov-Smirnov method. When data did not follow Gaussian distribution, Mann-Whitney U test was used instead. Log-rank test was used when survival was assessed as an end point. Data from human samples were also tested for Gaussian distribution, and differences between the groups presented with diverse hepatic damage scores were analyzed using Kruskal-Wallis test with Dunn's multiple comparisons or nonparametric Kendal linear trend post test. The linear trend post test was used to evaluate the pattern of variation of free heme, TNF, ferritin, transferrin saturation, or parasite load correlating with the ascending degree of hepatic damage. The statistical analysis of the human data was performed using STATA10 software (StataCorp LP, College Station, TX). Correlations between free heme, TNF, CRP, IL-6, ferritin, transferrin saturation, parasitemia, hepatic damage score, and creatinine were analyzed by Spearman nonparametric test. Nonlinear curve fit models were used to illustrate the overall trend of data variation. p < 0.05 was considered significant.
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